Neeta Mathur

Here's a glimpse of the company's performance and key highlights: ✔️ PI reported consolidated solid revenue growth of 31% YoY in 2QFY23, led by both CSM/Domestic businesses on the back of strong volume growth of 25%/31%, respectively ✔️It aims to commercialize seven new molecules in the CSM business and launch seven new products in the domestic industry in FY23. ✔️ It has levers in place to sustain the near-term growth momentum, led by: • Sustained growth momentum in the CSM business, driven by a strong order book, the rising pace of commercialization of new molecules, and sales of the ramp-up in existing molecules, • Product launches in the domestic market, thus providing earnings visibility. Would you be investing in PI Industries Ltd. Limited? Do let us know in the comments 💬 section. ⬇️Download the 👇 apps now! MO Investor app: http://ow.ly/huk250LqplcResearch360 app: http://ow.ly/Cup350Lqplf🔗 Disclaimer: http://ow.ly/63nS50Lqple▶️ Share this with your investing buddy. . 🔖 Save this post for future reference. . ☑️ Follow us for well-researched stock performance and key highlights. #MotilalOswal #CompanySpotlight #PIIndustriesLtd #experttips #chooserightstocks #investmentadvice #stockmarket #stockrecommendations #stockratings #stockanalysis #fundamentalanalysis #technicalanalysis #technicalreserach #marketanalysis #expertadvice #MotilalOswal #CompanySpotlight #PIIndustriesLtd #experttips #chooserightstocks #investmentadvice #stockmarket #stockrecommendations #stockratings #stockanalysis #fundamentalanalysis #technicalanalysis #technicalreserach #marketanalysis #expertadvice